Related references
Note: Only part of the references are listed.Progression rate of myelopathy in X-linked adrenoleukodystrophy heterozygotes
Clarissa Troller Habekost et al.
METABOLIC BRAIN DISEASE (2015)
Pathophysiology of X-linked adrenoleukodystrophy
J. Berger et al.
BIOCHIMIE (2014)
Neuroinflammation: The role and consequences
Monty Lyman et al.
NEUROSCIENCE RESEARCH (2014)
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics
Clarissa Troller Habekost et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Cytokine Levels in the Serum of Healthy Subjects
Giulio Kleiner et al.
MEDIATORS OF INFLAMMATION (2013)
Central nervous system inflammation in disease related conditions: Mechanistic prospects
Anthony Fung et al.
BRAIN RESEARCH (2012)
Cytokines and brain excitability
Michael A. Galic et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
Troy C. Lund et al.
PLOS ONE (2012)
Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked Adrenoleukodystrophy
Fernanda dos Santos Pereira et al.
PLOS ONE (2012)
Resolving postoperative neuroinflammation and cognitive decline
Niccolo Terrando et al.
ANNALS OF NEUROLOGY (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays
Hyun Ok Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
X-linked adrenoleukodystrophy: Clinical course and minimal incidence in South Brazil
Laura Bannach Jardim et al.
BRAIN & DEVELOPMENT (2010)
Biochemical Aspects of X-Linked Adrenoleukodystrophy
Stephan Kemp et al.
BRAIN PATHOLOGY (2010)
Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?
Florian S. Eichler et al.
ANNALS OF NEUROLOGY (2008)
Cytokines and anti-cytokines as therapeutics - An update
Vandana Tayal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Role of Th1 and Th17 cells in organ-specific autoimmunity
Valerie Dardalhon et al.
JOURNAL OF AUTOIMMUNITY (2008)
Novel approaches to therapy of hypereosinophilic syndromes
Hans-Uwe Simon et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Immunopathogenesis of adrenoleukodystrophy: Current understanding
Michelle P. Hudspeth et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
X-linked adrenoleukodystrophy
Hugo W. Moser et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Adrenoleukodystrophy - New approaches to a neurodegenerative disease
HW Moser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
C Peters et al.
BLOOD (2004)
Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies
AS Paintlia et al.
NEUROBIOLOGY OF DISEASE (2003)
Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: Morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation
M Ito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening
L Bezman et al.
ANNALS OF NEUROLOGY (2001)
Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy
A Di Biase et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)